AllSquare Wealth Management’s Takeda Pharmaceutical TAK Stock Holding History

AllSquare Wealth Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-408	Closed	-$7K	–	487
2020 Q3	$7K	Hold	408	–	–	0.01%	367
2020 Q2	$7K	Hold	408	–	–	0.01%	367
2020 Q1	$6K	Hold	408	–	–	0.01%	354
2019 Q4	$8K	Hold	408	–	–	0.01%	349
2019 Q3	$7K	Hold	408	–	–	0.01%	357
2019 Q2	$7K	Hold	408	–	–	0.01%	371
2019 Q1	$8K	Buy	408 +100	+32%	+$2.01K	0.01%	358
2018 Q4	$5K	Buy	+308	New	+$5.2K	﹤0.01%	385

Other funds holding TAK

GCM

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Adelphi Capital London, United Kingdom $3.21M AUM 121.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

AllSquare Wealth Management's TAK Position: Q4 2020 in Review

AllSquare Wealth Management sold out of Takeda Pharmaceutical (TAK) in Q4 2020, closing a stake of 408 shares — an estimated $7K sold.

AllSquare Wealth Management first reported a position in TAK in Q4 2018 and held it in 8 quarters. The position peaked at $8K in Q4 2019. 313 funds tracked by Wall St. Rank hold TAK as of Q4 2020.

AllSquare Wealth Management reported no remaining Takeda Pharmaceutical position as of Q4 2020 after selling out during the quarter.
AllSquare Wealth Management sold 408 Takeda Pharmaceutical shares in Q4 2020, an estimated $7K.
AllSquare Wealth Management first reported a position in Takeda Pharmaceutical in Q4 2018 and held it in 8 quarters.
AllSquare Wealth Management's Takeda Pharmaceutical position peaked at $8K in Q4 2019.
313 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q4 2020.

Based on AllSquare Wealth Management's 13F filing for Q4 2020, filed 9 Feb 2021.